Therapy News

AmpliPhi has just signed a Collaborative Research and Development Agreement (CRADA) with the US Army Medical Research and Development Command and the Walter Reed Army Institute of Research for developing and commercializing phage-based therapies to treat drug-resistant bacterial infections.
Wall Street Journal, July 2013

AmpliPhi and Phage Services combine, September 2012

Bacteriophage are used to generate electricity at UC Berkeley. May 2012

JAFRAL Phage Production News Release, March 2012

Phage fights Listeria in Agriculture in the Netherlands. March 2012

Amplifphi Biosciences demonstrates the efficacy of Bacteriophage Therapy in a controlled setting. November 2011.

OmniLytics has relocated from Salt Lake City to Sandy, Utah, US to expand its manufacturing capabilities. In 2010 OmniLytics produced nearly 100,000 litres of bacteriophage product and moving to a site with 60,000 sq ft (from 10,000) of lab and manufacturing space will support continued growth.

Justin Reber, CEO of OmniLytics, said: “This move not only significantly increases our manufacturing capabilities, but also provides the potential for future expansion onto an additional seven acres of undeveloped property acquired adjacent to the four acre, two building campus.”
OmniLytics is also nearing completion of a master plan for the production facility. This will provide equipment to support production of millions of litres of bacteriophage final product a year. May 2011. Source

Excellent podcast on bacteriophages from Microbe World, May 2011

BioControl has been purchased by Targeted Genetics. Biocontrol will start to do work against bacterial infections. February 2011

Venigalla Rao at CUA Gets Gates Foundation Grant to Develop T4 as a Vector For HIV Vaccination. January 2011

Phage used by AmpliPhi to clear lung infections. October 2012

Our keynote speaker from last year was nominated by the Department of Defense. October 2012

Old phage site: (last update 2009)

Dr. Jason Gill, who for the last several years has been the Program Director at the Center for Phage Technology at Texas A&M, is now taking a faculty position affiliated with the Center in the Department of Animal Science at Texas A&M.